Pancreatic ductal adenocarcinoma (PDAC) remains highly aggressive, with a five-year survival rate under 13.3%, due to late diagnosis, rapid progression, and therapeutic resistance, highlighting the need for advanced treatments. GAIP-interacting protein C termi... ...

请注册登录后继续浏览